©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Feb 28, 2022; 14(2): 30-46
Published online Feb 28, 2022. doi: 10.4329/wjr.v14.i2.30
Published online Feb 28, 2022. doi: 10.4329/wjr.v14.i2.30
Acute coronary syndrome on non-electrocardiogram-gated contrast-enhanced computed tomography
Shu Yoshihara, Department of Diagnostic Radiology, Iwata City Hospital, Iwata 438-8550, Japan
Author contributions: Yoshihara S designed and performed all of this study and wrote the all of the revised manuscript.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Corresponding author: Shu Yoshihara, MD, PhD, Doctor, Department of Diagnostic Radiology, Iwata City Hospital, 512-3 Ookubo, Iwata 438-8550, Japan. shuy@hospital.iwata.shizuoka.jp
Received: October 18, 2021
Peer-review started: October 18, 2021
First decision: December 10, 2021
Revised: December 14, 2021
Accepted: February 15, 2022
Article in press: February 15, 2022
Published online: February 28, 2022
Processing time: 130 Days and 12.8 Hours
Peer-review started: October 18, 2021
First decision: December 10, 2021
Revised: December 14, 2021
Accepted: February 15, 2022
Article in press: February 15, 2022
Published online: February 28, 2022
Processing time: 130 Days and 12.8 Hours
Core Tip
Core Tip: Definitive diagnosis of acute coronary syndrome (ACS) is sometimes difficult to achieve, especially in patients who present with atypical symptoms, normal initial biomarkers of myocardial necrosis, and normal or nondiagnostic electrocardiograms (ECGs). In order to avoid inappropriate management for this life-threatening event, clinicians should be aware that myocardial perfusion defect is more commonly detectable even on routine non-ECG-gated contrast-enhanced computed tomography performed in search of other pathologies. In this review, several essential points of image interpretation in diagnosing ACS on non-ECG-gated contrast-enhanced computed tomography has been described.
